Cogent Biosciences, Inc. (“Cogent”, “we”, “us”, “our”) sponsors ethically approved clinical trials (“Trial” or “Trials”). When you visit our website or participate or work in one of the Trials, we sponsor, you trust us with your personally identifiable information (“Personal Data”). We are committed to keeping that trust. That starts with helping you understand our privacy practices.This privacy notice (“Notice”) explains:• Who we are, and how to contact us, our DPO, or our representatives in the EU or the UK, with comments and questions• The scope of this Notice• The types of Personal Data we collect• How we obtain your Personal Data• How we use your Personal Data• How we legitimize the use of your Personal Data• How long your data is kept• The limited circumstances under which your Personal Data may be shared with others• Our global data transfer practices• Our data security policies and practices• Your data protection rights and how to exercise them• How we manage updates to this Notice
If you are an individual patient and you have any questions about this Notice or our processing of your Personal Data, or you would like to exercise your data protection rights, please first speak with your study doctor. Cogent generally only has access to key-coded data and we will be unable to identify you if we receive a request from you directly.Please allow up to one month for us to reply.
Legal entity name: Cogent Biosciences, Inc.
Address: 200 Cambridge Park Drive, Suite 2500, Cambridge, MA 02140, United States of America
Email address: Trialinfo@cogentbio.com
For the attention of: Zia Maharaj, Senior Privacy Counsel
Legal entity name: VeraSafe, LLC
Address: 100 M Street S.E., Suite 600, Washington, D.C. 20003 USA
Email address: firstname.lastname@example.org
VeraSafe Ireland Ltd
Unit 3D North Point House, North Point Business Park, New Mallow Road, Cork T23AT2P,
Contact form: https://www.verasafe.com/privacy-services/contact-article-27-representative
VeraSafe United Kingdom Ltd.
37 Albert Embankment, London SE1 7TL, United Kingdom
Phone: +44 (20) 4532 2003Contact form: https://www.verasafe.com/privacy-services/contact-article-27-representative
This Notice specifically applies to:
• individual patients and potential Trial participants in connection with our Trials and use of our experimental pharmaceutical products and/or future commercialized pharmaceutical products (if any);
• health care providers and other study site personnel, in connection with our Trials; and the
• website visitors of https://www.cogentbio.com/ and https://cogentclinicaltrials.com/, including those who contact us at email@example.com or TrialInfo@cogentbio.com.
This Notice does not apply to Personal Data collected by any other means or in other contexts, such as the Personal Data of Cogent’s employees, job applicants, contractors, business owners, officers, directors or staff of Cogent. This means, for example, that this Notice does not describe our processing of your Personal Data nor your data protection rights when you apply to one of our job openings on our website.
If we maintain information in a manner that cannot reasonably identify, relate to, describe, be capable of being associated with, or be linked, directly or indirectly, with a particular individual or household, such information is not considered Personal Data and this Notice will not apply to our processing of that information.
Within the scope of this Notice, Cogent acts as a data controller for the Personal Data processed in the context of the Trials we sponsor and for the processing of your Personal Data that takes place when you visit our website. This means that we decide how and why Personal Data is collected and processed, or, in other words, we determine the purpose and means of the processing of your Personal Data.In some jurisdictions, we may be considered a “joint controller” with another organization, such as the study site where the Trial is being conducted. This means that we jointly, together with the other organization, determine the purpose and means of the processing of your Personal Data. If you would like to know more about any other data controllers who might be joint controllers together with Cogent, you may ask your study doctor or the study site for further details, specifically relating to the Trial that you are participated in.
Even though we are a data controller for the Personal Data processed in the context of our Trials, Cogent itself does not have access to identifiable Personal Data, meaning that we are unable to identify you personally from the information we have access to. Personal Data is collected by our service providers like the study site (the clinic or other healthcare facility where the Trial is being run) or other third parties, such as your doctors or our clinical research organizations. When any information relating to you is shared with us by our service providers, it will first be key-coded (also known as “pseudonymized”) so that we cannot identify you by any direct personal identifier (such as your name, social security number, address, or telephone number).
The following types of Personal Data of individual Trial participants may be processed in the context of our Trials:
• basic identifying information, such as your first and last name;
• contact information, such as your phone number, physical address and email address;
• location information, such as the location of your testing site and Trial location (i.e., study site);
• health care information, such as the identity and contact information of your doctors and other health care providers;
• health information, such as your medical history, current health status and reaction to the Trial drug or treatment;
• your genetic information; and/or
• identifiers and device information, such as IP address and associated location, operating system, and device IDs (e.g., when you visit a Trial-specific website).
You can ask your study doctor if you are unsure whether or not any specific Personal Data that you are being asked to provide is required as part of your participation in the Trial.
We may process the following types of Personal Data about healthcare providers in the context of our Trials:
• basic identifying information, such as your first and last name;
• contact information, such as your phone number, physical address and email address;
• professional and employment related information, such as your qualifications and job titles; and/or
• location information, such as the location of your testing site and Trial location (i.e., study site).
We may process the following types of Personal Data about website visitors that use our contact form:
• basic identifying information, such as your first and last name;
• contact information, such as your phone number, physical address and email address; and/or
• whatever information the individual shares with us in their message.
We may receive your Personal Data when:
• you provide it directly to us (including when you provide your Personal Data to one of our service providers acting on our behalf);
• a study doctor (also known as an “investigator”) or other healthcare personnel at the study site provides it to us, or your healthcare provider provides it to us;
• we receive it from the clinical research organization that conducts the Trial on our behalf;
• you visit one of our Trial-specific websites or online portals; and/or
• you provide it to us, the clinical research organization, or a study doctor when you complete a pre-screening questionnaire to confirm your eligibility to participate in the Trial.
We may process your Personal Data for the purposes of:
• responding to your requests or questions;
• processing your requests to exercise your data protection rights;
• managing and facilitating the Trial;
• enabling your participation in the Trial;
• answering the research questions for the Trial and aggregating data to generate statistics relating to the Trial and/or study drug or health treatment;
• arranging for the delivery of drugs to you and collection of unused drugs from you in relation to the Trial;
• arranging your transportation to or from the study site and overnight accommodations, as needed;
• sending you reminders about your appointments at the study site, or to take your medication on time;
• monitoring and reporting on any adverse events, such as negative side effects;
• developing new medicinal drugs or health treatments;
• complying with legislation governing Trials;
• disclosing your Personal Data to the appropriate regulatory authorities, auditors, and ethics committees, if required by law; and/or
• communicating with you on the status of the Trial.
We also process your Personal Data for the specific purposes described in the informed consent form provided to you by Trial personnel.
We may process your Personal Data on the basis of:
• Consent: We may ask for your consent to collect and process your Personal Data, including special categories of Personal Data, such as your health status and medical history.
• Contract: We may process your Personal Data to fulfill a contract we have with you.
• Legitimate Interests: We may process your Personal Data based on our legitimate interests in facilitating and managing our Trials.
• Compliance with Legal Obligations: We may need to process your Personal Data for us to comply with applicable laws or regulations, such as the laws regulating the safety and reliability of our Trials.
• Public Interest: We may process your Personal Data for reasons of public health interests to ensure adequate standards of quality and safety of the experimental pharmaceutical products or treatments we are developing.
Where we process your Personal Data based on your consent, you may withdraw your consent at any time. However, this will not affect the lawfulness of our processing before you withdrew your consent. It will also not affect processing performed on other lawful grounds. If you withdraw your consent, you may be ineligible to participate in the Trial.
Where we receive your Personal Data as part of a contract we may have with you, we require such Personal Data to be able to carry out the contract. Without that necessary Personal Data, we will not be able to fulfill our contractual obligation towards you.
When we rely on legitimate interests as a lawful basis of processing, you have the right to ask us more about how we decided to choose this legal basis. To do so, please use the contact details provided here.
Since we process special categories of Personal Data, such as your health status and medical history, the EU General Data Protection Regulation (“GDPR”) requires that we must have an additional legal ground to process this type of information. Cogent may process your special categories of Personal Data on the basis of your explicit consent, or where the processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes.
The specific grounds on which we process your Personal Data, including your health data, may vary somewhat from the above in order to comply with the requirements of local laws in jurisdictions where we sponsor Trials. If you are a participant in a Trial, please refer to the informed consent form you signed when you joined the Trial for more information about the legal grounds on which we process your Personal Data.
If you participate in a Trial we sponsor, you will be assigned a unique patient identification number. For a given Trial, this number may be used as part of an automatic process that randomly determines what level dose of the experimental drug product you will receive. This number may also be used as part of an automatic process that randomly determines if you will receive the experimental drug product or treatment that is being evaluated in a given Trial, or if you will receive a placebo or different treatment. This type of automated decision-making is required in order to ensure that the applicable Trial is conducted in an ethical way, and in accordance with the pharmaceutical industry’s standards.
For decisions that may seriously impact you, you have the “right not to be subject to automatic decision-making, including profiling”. But in those cases, we will always explain to you when we might do this, why it is happening, and the potential effect on you.
We will retain your Personal Data for as long as is necessary to fulfil the purpose for which we collected your Personal Data (listed above) and any other permitted linked purpose, and in compliance with our data retention policies as applicable from time to time. For example, we will retain and use your Personal Data to the extent necessary to comply with our legal obligations (for example, if we are required to retain your data to comply with applicable laws), resolve disputes, and enforce our legal agreements and policies.Once your information has been entered into the Trial records, we cannot remove it without affecting the accuracy of the Trial and the test results. Some laws require us to keep Trial records for at least 25 years after the conclusion of the Trial. We will ensure that your Personal Data is safeguarded at all times.
We may share Personal Data with our service providers who process Personal Data on our behalf, and who agree to use the Personal Data only to assist us in fulfilling the purposes of processing as described in Section 7 above, or as required by law. Our service providers may include parties providing the following, either currently or in the future:
• contract/clinical research organization services;
• patient recruitment services;pathology laboratories;
• clinical pharmacology services;laboratory services;
• data management and biostatistics services;
• cardiac safety services;trial oversight, imaging and digital patient services;
• quality assurance, safety and pharmacovigilance software and related services;
• data storage and archiving software and related services;
• data analytics and reporting software and services;
• services related to the collection, storage, testing, and transportation of biological material;
• software that randomly decides which dose level or treatment you will receive during the Trial;
• logistics and transport service providers; and/or
• electronic data capture software and hardware.
The GDPR only allows us to transfer Personal Data outside of the European Union (“EU”) or the European Economic Area (“EEA”) if the country that the data is being transferred to offers an adequate level of protection for the Personal Data which is equivalent to EU law. Cogent is situated in the United States of America (“USA”), outside the EU/EEA. We have implemented various safeguards to protect Personal Data, which enables us to receive EU Personal Data in the USA.Some of our third party service providers described above may also be located in countries outside of the EU/EEA. In some cases, the European Commission may have determined that the laws of certain countries provide a level of protection to Personal Data. You can see here the list of countries that the European Commission has recognized as providing an adequate level of protection to Personal Data.For transfers of Personal Data to third countries which are not recognized as providing an adequate level of protection, we will only transfer EU Personal Data to third parties in those countries when there are appropriate safeguards in place. These safeguards may include the Standard Contractual Clauses as approved by the European Commission under Article 46.2 of the GDPR.
We may disclose your Personal Data:
• with regulators or competent authorities, to the extent necessary to comply with applicable laws, regulations and rules (including, without limitation, federal, state or local laws);
• to the extent required by law, or if we have a good-faith belief that we need to disclose it in order to comply with official investigations or legal proceedings (whether initiated by governmental/law enforcement officials, or private parties);
• if, in the future, we sell or transfer, or consider selling or transferring, part or all of our company, business, shares or assets to a third party, and we disclose your Personal Data to such third party in connection with the sale or transfer; and/or
• in the event that we are acquired by, or merged with, a third-party entity, or in the event of bankruptcy or a comparable event, we reserve the right to transfer, disclose or assign your Personal Data in connection with the foregoing events.
If we have to disclose your Personal Data to governmental/law enforcement officials, we may not be able to ensure that those officials will maintain the privacy and security of your Personal Data.
We have implemented and will maintain technical, administrative, and physical measures that are reasonably designed to help protect Personal Data from unauthorized processing. This includes unauthorized access, disclosure, alteration, or destruction.
You have specific rights regarding your Personal Data that we collect and process.For individual patients: to exercise the rights we explain below, please first speak with your study doctor instead of contacting us directly.To exercise your data protection rights, email TrialInfo@cogentbio.com and add DATA PROTECTION REQUEST to the subject line. Provide as much information that you consider fit to help us identify you and swiftly treat your request.
This is called the “right to be informed”. It means that you have the right to obtain from us all information regarding our data processing activities that concern you (or your child), such as how we collect and use your Personal Data, how long we will keep it, and who it will be shared with, among other things.
We are informing you of how we process your Personal Data with this Notice.
This is called the “right of access”. This right allows you to ask for full details of the Personal Data we hold about you.
Once we receive and confirm that the request came from you or your authorized agent, we will disclose to you:
• The categories of your Personal Data that we process;
• The categories of sources for your Personal Data;
• Our purposes for processing your Personal Data;
• Where possible, the retention period for your Personal Data, or, if not possible, the criteria used to determine the retention period;
• The categories of third parties with whom we share your Personal Data;
• If we carry out automated decision-making, including profiling, meaningful information about the logic involved, as well as the significance and the envisaged consequences of such processing for you;
• The specific pieces of Personal Data we process about you in an easily-sharable format;
• The categories of parties that received your Personal Data from us;
• If we rely on legitimate interests as a lawful basis to process your Personal Data, the specific legitimate interests; and
• The appropriate safeguards used to transfer Personal Data from the EEA to a third country, if applicable.
Under some circumstances, we may deny your access request. In that event, we will respond to you with the reason for the denial.
This is called the “right to rectification”. It gives you the right to ask us to correct anything that you think is wrong with the Personal Data we have on file about you (or your child), and to complete any incomplete Personal Data.
This is called the “right to erasure”, “right to deletion”, or the “right to be forgotten”. This right means you can ask for your Personal Data to be deleted.
Sometimes we can delete your information, but other times it is not possible for either technical or legal reasons. If that is the case, we will consider if we can limit how we use it. We will also inform you of our reason for denying your deletion request.
This is called the “right to restrict processing”. It is the right to ask us to only use or store your Personal Data for certain purposes. You have this right in certain instances, such as where you believe the data is inaccurate or the processing activity is unlawful.
This is called the “right to object”. This is your right to tell us to stop using your Personal Data. You have this right where we rely on a legitimate interest of ours (or of a third party). You may also object at any time to the processing of your Personal Data for direct marketing purposes.We will stop processing the relevant Personal Data unless: (i) we have compelling legitimate grounds for the processing that override your interests, rights, or freedoms; or (ii) we need to continue processing your Personal Data to establish, exercise, or defend a legal claim.
This is called the “right to data portability”. It is the right to ask for and receive a portable copy of your Personal Data that you have given us, so that you can:
• Move it;
• Copy it;
• Keep it for yourself; and/or
• Transfer it to another organization.
We will provide your Personal Data in a structured, commonly used, and machine-readable format. When you request this information electronically, we will provide you a copy in electronic format.
We sometimes use computers to study your Personal Data. For decisions that may seriously impact you, you have the right not to be subject to automatic decision-making, including profiling. But in those cases, we will always explain to you when we might do this, why it is happening and the effect.
Where we rely on your consent as the legal basis for processing your Personal Data, you may withdraw your consent at any time. If you withdraw your consent, our use of your Personal Data before you withdraw is still lawful.
As discussed above, if we requested your consent to process your Personal Data, you have the right to withdraw your consent at any time. However, this will not affect the lawfulness of our processing before you withdrew your consent. It will also not affect processing performed on other lawful grounds. If you withdraw your consent, you may be ineligible to participate in the Trial.
If the GDPR applies to our processing of your Personal Data, you have the right to lodge a complaint with a supervisory authority if you are not satisfied with how we process your Personal Data.
Specifically, you can lodge a complaint in the Member State of the European Union of your habitual residence, place of work, or the alleged violation of the GDPR.
If we change this Notice, we will publish the revised Notice on our website. We will also update the “Effective” date.